CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
RadAR EasyCLik plus ®-STF hemostatic pad +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03522077
NCT03522077N/ACompleted

RAVE: Radial Artery Vascular Complication and Resource Utilization in Subjects Undergoing an Angiogram/PCI (Percutaneous Coronary Intervention)

Wake Forest University Health Sciences·interventional·Posted May 11, 2018·Updated Oct 3, 2024

In Brief

A clinical study evaluating RadAR EasyCLik plus ®-STF hemostatic pad, TR BAND® Compression device plus ®-STF hemostatic pad, and 2 other interventions for Angiogram and Percutaneous Coronary Intervention. Completed, enrolled 300 participants across 1 site.

Detailed Summary

The primary objective of this study is to determine if there is a reduction in time to hemostasis in subjects treated with SoftSeal®-STF hemostatic pad when used in conjunction with a vascular compression device after radial transcatheter procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsChitogen, Inc.

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 11, 2018
Enrollment StartMay 9, 2018
Primary CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8.1 years ago

Interventions

RadAR EasyCLik plus ®-STF hemostatic paddevice

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot in conjunction with the RadAR EasyCLik compression device

TR BAND® Compression device plus ®-STF hemostatic paddevice

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot in conjunction with the TR BAND® compression device

SoftSeal®-STF hemostatic paddevice

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot

VascBand™ Hemostatdevice

The VascBand™ Hemostat is an FDA-approved compression device designed to assist hemostasis of arterial, venous and hemodialysis percutaneous access sites.